These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 24187096)

  • 21. Generalized estimating equation model to compare drug effects on synovitis of the dominant wrist in severe rheumatoid arthritis between tocilizumab versus adalimumab versus abatacept using high-resolution ultrasound.
    Chen YC; Chiu WC; Su FM; Chen JF
    Int J Rheum Dis; 2018 Sep; 21(9):1695-1700. PubMed ID: 29024421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis.
    Taylor PC; Steuer A; Gruber J; McClinton C; Cosgrove DO; Blomley MJ; Marsters PA; Wagner CL; Maini RN
    Arthritis Rheum; 2006 Jan; 54(1):47-53. PubMed ID: 16385521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rheumatoid hand joint synovitis: gray-scale and power Doppler US quantifications following anti-tumor necrosis factor-alpha treatment: pilot study.
    Ribbens C; André B; Marcelis S; Kaye O; Mathy L; Bonnet V; Beckers C; Malaise MG
    Radiology; 2003 Nov; 229(2):562-9. PubMed ID: 12970463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of total arthroplasty combined with anti-tumor necrosis factor agents in attenuating systemic disease activity in patients with rheumatoid arthritis.
    Hayashi M; Kojima T; Funahashi K; Kato D; Matsubara H; Shioura T; Kanayama Y; Hirano Y; Ishiguro N
    Mod Rheumatol; 2012 Jun; 22(3):363-9. PubMed ID: 21979824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic efficacy of tocilizumab in patients with rheumatoid arthritis refractory to anti-tumor-necrosis-factor inhibitors: 1 year follow-up with low-field extremity MRI.
    Suzuki T; Horikoshi M; Sugihara M; Hirota T; Ogishima H; Umeda N; Kondo Y; Tsuboi H; Hayashi T; Chino Y; Matsumoto I; Sumida T
    Mod Rheumatol; 2013 Jul; 23(4):782-7. PubMed ID: 22975733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab.
    Filippucci E; Iagnocco A; Salaffi F; Cerioni A; Valesini G; Grassi W
    Ann Rheum Dis; 2006 Nov; 65(11):1433-7. PubMed ID: 16504996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of ultrasound subclinical synovitis and increment of serum vascular endothelial growth factor in a patient with rheumatoid arthritis achieved in sustained clinical remission by treatment with adalimumab and methotrexate.
    Kawashiri SY; Arima K; Suzuki T; Nakashima Y; Horai Y; Okada A; Tamai M; Nakamura H; Kawakami A
    Mod Rheumatol; 2014 Jul; 24(4):681-4. PubMed ID: 24533548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive synovial vascularity in patients with low disease activity indicates smouldering inflammation leading to joint damage in rheumatoid arthritis: time-integrated joint inflammation estimated by synovial vascularity in each finger joint.
    Fukae J; Isobe M; Kitano A; Henmi M; Sakamoto F; Narita A; Ito T; Mitsuzaki A; Shimizu M; Tanimura K; Matsuhashi M; Kamishima T; Atsumi T; Koike T
    Rheumatology (Oxford); 2013 Mar; 52(3):523-8. PubMed ID: 23192908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics.
    Kawashiri SY; Kawakami A; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Arima K; Ichinose K; Kamachi M; Yamasaki S; Nakamura H; Origuchi T; Ida H; Eguchi K
    Mod Rheumatol; 2010 Feb; 20(1):40-5. PubMed ID: 19802651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with radiographic progression in patients with rheumatoid arthritis who were treated with methotrexate.
    Weinblatt ME; Keystone EC; Cohen MD; Freundlich B; Li J; Chon Y; Baumgartner SW
    J Rheumatol; 2011 Feb; 38(2):242-6. PubMed ID: 21078715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of early active rheumatoid arthritis to tumor necrosis factor inhibitors: evaluation by magnetic resonance imaging.
    Hirose W; Nishikawa K; Hirose M; Nanki T; Sugimoto H
    Mod Rheumatol; 2009; 19(1):20-6. PubMed ID: 18762862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The comparison of effects of biologic agents on rheumatoid arthritis damage progression is biased by period of enrollment: data from a systematic review and meta-analysis.
    Favalli EG; Pregnolato F; Biggioggero M; Meroni PL
    Semin Arthritis Rheum; 2014 Jun; 43(6):730-7. PubMed ID: 24332807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infliximab efficacy in rheumatoid arthritis after an inadequate response to etanercept or adalimumab: results of a target-driven active switch study.
    Fleischmann R; Goldman JA; Leirisalo-Repo M; Zanetakis E; El-Kadi H; Kellner H; Bolce R; DeHoratius R; Wang J; Decktor D
    Curr Med Res Opin; 2014 Nov; 30(11):2139-49. PubMed ID: 25050591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
    Cacciapaglia F; Anelli MG; Rinaldi A; Serafino L; Covelli M; Scioscia C; Iannone F; Lapadula G
    Drug Dev Res; 2014 Nov; 75 Suppl 1():S77-80. PubMed ID: 25381986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-enhanced ultrasonography is more sensitive than grayscale and power Doppler ultrasonography compared to MRI in therapy monitoring of rheumatoid arthritis patients.
    Ohrndorf S; Hensch A; Naumann L; Hermann KG; Scheurig-Münkler C; Meier S; Burmester GR; Backhaus M
    Ultraschall Med; 2011 Dec; 32 Suppl 2():E38-44. PubMed ID: 22052070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease remission state in patients treated with the combination of tumor necrosis factor blockade and methotrexate or with disease-modifying antirheumatic drugs: A clinical and imaging comparative study.
    Saleem B; Brown AK; Keen H; Nizam S; Freeston J; Karim Z; Quinn M; Wakefield R; Hensor E; Conaghan PG; Emery P
    Arthritis Rheum; 2009 Jul; 60(7):1915-22. PubMed ID: 19565512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasound can improve the accuracy of the 2010 American College of Rheumatology/European League against rheumatism classification criteria for rheumatoid arthritis to predict the requirement for methotrexate treatment.
    Nakagomi D; Ikeda K; Okubo A; Iwamoto T; Sanayama Y; Takahashi K; Yamagata M; Takatori H; Suzuki K; Takabayashi K; Nakajima H
    Arthritis Rheum; 2013 Apr; 65(4):890-8. PubMed ID: 23334942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.
    Inciarte-Mundo J; Ramirez J; Hernández MV; Ruiz-Esquide V; Cuervo A; Cabrera-Villalba SR; Pascal M; Yagüe J; Cañete JD; Sanmarti R
    Arthritis Res Ther; 2016 Jul; 18(1):160. PubMed ID: 27391315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Very early improvements in the wrist and hand assessed by power Doppler sonography predicting later favorable responses in tocilizumab-treated patients with rheumatoid arthritis.
    Kume K; Amano K; Yamada S; Hatta K; Kuwaba N; Ohta H
    Arthritis Care Res (Hoboken); 2011 Oct; 63(10):1477-81. PubMed ID: 21702090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.